Frequent Expression of CD99 in Anaplastic Large Cell Lymphoma

Daniel Buxton(Loma Linda University), Jun Wang(Shanghai Jiao Tong University), Carlos E. Bacchi(Laboratório Bacchi), Edward H. Rowsell, Gabrıela Gualco(Laboratório Bacchi), Craig W. Zuppan(Loma Linda University Medical Center), Lawrence M. Weiss(NeoGenomics (United States)), Qin Huang(People's Hospital of Xinjiang Uygur Autonomous Region)

American Journal of Clinical Pathology

March 16, 2009

10.1309/ajcpe68hzxcgwtkk

Cited by 35

Related Papers

Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages

|Blood|2016|1.6k

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program

|Blood|2013|683

Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study

|Blood|2012|396

Cloning of a new member of the peroxisome proliferator-activated receptor gene family from mouse liver.

|Journal of Biological Chemistry|1993|375

Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study

|Leukemia|2012|362